Ixazomib

ATC L01XG03 · 10 markets · 34 records

Ixazomib 10 markets · 34 records Forms

GB 9 records · 3 strengths

4 mgcapsuleNINLARO+1__no_trade__ also in US·CA·SG +2
3 mgcapsuleNINLARO+1__no_trade__ also in US·CA·SG +2
2.3 mgcapsuleNINLARO+1__no_trade__ also in US·CA·SG +2

US 3 records · 3 strengths

4 mgcapsuleNINLARO also in GB·CA·SG +2
3 mgcapsuleNINLARO also in GB·CA·SG +2
2.3 mgcapsuleNINLARO also in GB·CA·SG +2

CA 3 records · 3 strengths

4 mgcapsuleNINLARO also in GB·US·SG +2
3 mgcapsuleNINLARO also in GB·US·SG +2
2.3 mgcapsuleNINLARO also in GB·US·SG +2

AU 3 records · 3 strengths

5.7 mgcapsuleNINLARO ixazomib (as citrate) 4mg capsule blister pack unknown
4.3 mgcapsuleNINLARO ixazomib (as citrate) 4mg capsule blister pack unknown
3.29 mgcapsuleNINLARO ixazomib (as citrate) 4mg capsule blister pack unknown

SG 3 records · 3 strengths

4 mgcapsuleNINLARO also in GB·US·CA +2
3 mgcapsuleNINLARO also in GB·US·CA +2
2.3 mgcapsuleNINLARO also in GB·US·CA +2

CN 3 records · 3 strengths

4 mgcapsule恩莱瑞枸橼酸伊沙佐米 also in GB·US·CA +2
3 mgcapsule恩莱瑞枸橼酸伊沙佐米 also in GB·US·CA +2
2.3 mgcapsule恩莱瑞枸橼酸伊沙佐米 also in GB·US·CA +2

TW 3 records · 3 strengths

4 mgcapsuleNINLARO+1免瘤諾膠囊4毫克 also in GB·US·CA +2
3 mgcapsuleNINLARO+1免瘤諾膠囊3毫克 also in GB·US·CA +2
2.3 mgcapsuleNINLARO+1免瘤諾膠囊2.3毫克 also in GB·US·CA +2

HK 3 records · 1 strengths

Records without a stated strength · 1 NINLARO

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 NINLARO

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	CN	TW	HK	EU
4 mg capsule	NINLARO	No trade name NINLARO	NINLARO	not recorded	NINLARO	恩莱瑞枸橼酸伊沙佐米	NINLARO 免瘤諾膠囊4毫克	not recorded	not recorded
3 mg capsule	NINLARO	No trade name NINLARO	NINLARO	not recorded	NINLARO	恩莱瑞枸橼酸伊沙佐米	NINLARO 免瘤諾膠囊3毫克	not recorded	not recorded
2.3 mg capsule	NINLARO	No trade name NINLARO	NINLARO	not recorded	NINLARO	恩莱瑞枸橼酸伊沙佐米	NINLARO 免瘤諾膠囊2.3毫克	not recorded	not recorded
5.7 mg capsule	not recorded	not recorded	not recorded	NINLARO ixazomib (as citrate) 4mg capsule blister pack	not recorded	not recorded	not recorded	not recorded	not recorded
4.3 mg capsule	not recorded	not recorded	not recorded	NINLARO ixazomib (as citrate) 4mg capsule blister pack	not recorded	not recorded	not recorded	not recorded	not recorded
3.29 mg capsule	not recorded	not recorded	not recorded	NINLARO ixazomib (as citrate) 4mg capsule blister pack	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	NINLARO	NINLARO

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

4 more strength/form rows are recorded only in AU · HK · EU and are not shown in this table. Hay 4 filas de concentración/forma registradas solo en AU · HK · EU que no se muestran en esta tabla. 另有 4 个规格/剂型仅在 AU · HK · EU 有记录（未在本表显示）。另有 4 個規格/劑型僅在 AU · HK · EU 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.